Are Wall Street Analysts Predicting Healthpeak Properties Stock Will Climb or Sink?
UBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $22
Evercore ISI Group Maintains In-Line on Healthpeak Properties, Raises Price Target to $23
Healthpeak: 3 Key Takeaways for Long-Term Investors
Healthpeak Properties: Potential Life Science Rebound Creates A Strong Re-Rating Setup
Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Lowers Price Target to $21
What Healthpeak Properties (DOC) Said on Its Q3 Earnings Call
Healthpeak Properties Inc (DOC) (Q3 2026) Earnings Call Highlights: Third FFO Guidance Raise ...
Healthpeak Properties (DOC) Stock Shrugs Off Q3 Earnings As Refinancing Risk Lingers
Healthpeak (DOC) Q3 2026 Earnings Call Transcript
Healthpeak Properties, Inc. (DOC) Q3 2026 Earnings Call Transcript
Healthpeak Properties, Inc. Q3 2026 Earnings Call Summary
Healthpeak Properties Q3 2026 Earnings Call Transcript
Healthpeak: Q3 Earnings Snapshot
Healthpeak (DOC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Healthpeak (DOC) Q3 FFO and Revenues Surpass Estimates
Healthpeak Properties Reports Third Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance
Healthpeak Properties Raises FY2026 FFO Guidance from $1.73-$1.77 to $1.76-$1.78 vs $1.76 Est
Healthpeak Properties Q3 Adj. FFO $0.44 Beats $0.43 Estimate, Sales $820.892M Beat $736.787M Estimate
What's in the Cards for Healthpeak Properties This Earnings Season?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.